Piper Sandler Maintains Overweight on Aspen Aerogels, Raises Price Target to $30
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Alexander Potter has maintained an Overweight rating on Aspen Aerogels (NYSE:ASPN) and increased the price target from $29 to $30.
May 14, 2024 | 11:37 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Piper Sandler has reaffirmed its Overweight rating on Aspen Aerogels and raised the price target from $29 to $30, indicating a positive outlook on the stock.
The increase in price target by a reputable analyst like Piper Sandler suggests a strong confidence in Aspen Aerogels' future performance. This endorsement is likely to positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100